3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
1
Pain
1
Neoplasms
1
Esophageal Neoplasms
1
Disease
1
Breast Neoplasms
1
Breakthrough Pain
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Prednisone
4
Colonoscopy
4
Biopsy, Fine-Needle
4
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Mammography
3
Magnetic Resonance Imaging
3
Liquid Biopsy
3
Lenalidomide
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
Cyclophosphamide
3
weifuchun
2
pembrolizumab
2
obinutuzumab
2
Urination
2
Preoperative Exercise
2
Positron Emission Tomography Computed Tomography
2
Observation
2
Methods
2
Melphalan
2
Immunohistochemistry
2
Hematologic Tests
2
Gemcitabine
2
Educational Status
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Disease
×
Patient Positioning
×
Clear all
NCT02865239
2018-08-08
EFIMED
Institut de Cancérologie de Lorraine
Phase NA
Completed
15 enrolled